Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

This study determines the effectiveness of leuprolide acetate 45 mg for injectable suspension for treatment of children with Central Precocious Puberty.

See detailed information including eligibility.

05/2015
06/2017
NCT02452931
Pediatric Endocrinology
Accepting Participants